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Objectives. The purpose of this study was to assess whether the
severity of myocardial ischemia would be attenuated by repeated
daily ischemic episodes, recorded by ambulatory electrocardio-
graphic monitoring (AEM).
Background. Repetitive ischemic episodes induced by brief
coronary occlusions in animal experiments and in humans during
balloon coronary angioplasty produce preconditioning. We
wanted to assess whether this phenomenon also exists during
daily ischemic episodes.
Methods. Twenty-one patients with known coronary artery
disease and ischemia on exercise testing and AEM were requested
to walk a distance known to have previously caused myocardial
ischemia on three consecutive occasions. Walking time was
;15 min and was followed by 5 min of rest.
Results. Mean maximal heart rate during the three walks was
similar; however, the mean maximal ST segment depression
decreased significantly from 2.21 mm during the first walk to
1.61 mm and 1.43 mm, respectively, on the second and third walks
(p 5 0.001). Ischemia duration was also significantly reduced on
the second and third walks by 56% from 514 to 228 and 254 s,
respectively (p 5 0.012). The heart rate at onset of ischemia
(ischemic threshold) increased from 99 beats/min on the first walk
to 101 beats/min on the second walk and to 106 beats/min on the
third walk (p 5 0.058).
Conclusions. This study demonstrated attenuation of myocar-
dial ischemia with an associated increase in ischemic threshold in
patients with repeated and adjacent ischemic episodes. This form
of myocardial protection is likely to be encountered in patients
during ordinary activity and may represent the clinical counter-
part of myocardial preconditioning.
(J Am Coll Cardiol 1997;30:119–24)
©1997 by the American College of Cardiology
Patients with coronary artery disease who have frequent isch-
emic episodes have a worse prognosis than that of patients
without such episodes. This adverse outcome was demon-
strated in patients with stable (1–4) and unstable angina (5,6)
in postinfarction patients (7,8) and in patients with ischemia
induced by exercise (9–11) or mental stress (12). It is uncertain
whether patients with frequent ischemic episodes have more
advanced disease or whether the increased risk is related to the
repeated ischemia. Our previous studies (2,3) in patients with
stable angina and positive exercise test results have shown that
patients with repeated ischemic episodes recorded on ambu-
latory electrocardiographic monitoring (AEM) have a worse
prognosis than that of patients without evidence of ischemia
during daily activity despite similar ischemic changes in the two
groups during exercise. These observations suggest that re-
peated ischemia adversely affects prognosis. In contrast, exper-
imental evidence has suggested that repeated ischemia may
confer myocardial protection from further ischemia. In animal
models of temporary coronary occlusion (13), this phenome-
non was termed “preconditioning.” In clinical practice (14–16)
the terms “warm-up angina” or “walk-through angina” have
been used to describe the ability of a patient with angina to
continue walking without chest pain after an initial anginal
attack.
Preconditioning was initially demonstrated by Murry et al.
(13) in dogs. They showed that after four periods of 5 min of
coronary occlusion there was a significant reduction in infarct
size caused by a subsequent 40-min coronary occlusion. The
temporal aspects of preconditioning in animal models have
been defined (17–19). In dogs, a single brief episode of 2.5 min
caused preconditioning that lasted up to 2 h (20). Precondi-
tioning has also been shown to protect against ischemia-
induced arrhythmias (21,22) and to enhance recovery of con-
tractile function after ischemia (23).
To date there have been few studies of preconditioning in
humans (24–28). Deutch et al. (24) showed that patients
undergoing balloon angioplasty experienced less severe isch-
emia during later balloon inflations if the initial inflation lasted
90 s. However, if the initial inflation lasted only 60 s, this
protection did not occur. Inoue et al. (28) performed repeated
balloon inflations in 20 patients with coronary artery disease
and found a reduction in ST elevation with no increase in
coronary flow despite elevated O2 saturation in the great
cardiac vein and elevated serum adenosine levels. These
findings imply that there was no recruitment of collateral
vessels and that local cellular mechanisms were responsible for
the reduction in ischemia. Williams et al. (29) demonstrated
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the warm-up phenomenon during two periods of pacing-
induced tachycardia separated by a brief recovery period.
Recently, several retrospective studies (30–34) have shown
improved outcome after myocardial infarction in patients who
experienced prior angina. The investigators attributed this
protection to the development of preconditioning.
In 1897 Osler (35) described walk-through angina as angi-
nal pain that a patient could overcome by persisting in effort.
This phenomenon was also noted by Wenckebach (36,37) in
the 1920s. MacAlpin and Kattus (38) examined 12 patients
with exertional chest pain and positive exercise test results. The
subjects walked on a treadmill at a speed that was gradually
increased until ST segment depression or anginal pain ap-
peared; the speed was then kept constant until exercise was
stopped. Nine of the patients were able to continue walking
after the onset of angina with eventual disappearance or
lessening of both anginal pain and associated ST depression.
The purpose of this study was to assess whether severity of
myocardial ischemia will be attenuated in patients with re-
peated and adjacent (15 min apart) ischemic episodes.
Methods
Patient selection. Twenty-one patients, 20 men and 1
woman, with stable symptomatic coronary artery disease and
evidence of ischemia on both exercise testing and AEM, were
studied. All patients had proved coronary artery disease, based
on at least one of the following: angiographic evidence of
significant coronary stenosis (n 5 16), a history of myocardial
infarction (n 5 7) or a positive exercise test result accompa-
nied by chest pain (n 5 12). All patients had had a positive
exercise test result before entering the study, with at least
1-mm ST segment depression in two electrocardiographic
(ECG) leads. In addition, all had at least two ischemic episodes
during a 24-h period as recorded by AEM. Patients with
unstable angina or recent myocardial infarction, coronary
artery bypass surgery or angioplasty within 3 months were
excluded. All patients stopped antianginal medication 48 h
before the study day. The study was approved by the institu-
tional ethics committee and all patients gave informed written
consent.
Experimental protocol. The patients were requested to
find a route near their home where they were used to walking.
The route was required to be circular, to include an incline and
to take them about 15 min at a regular pace. The patients were
asked to perform this walk three times, resting for 5 min
between each walk. The patients were connected to a Marque-
tte 8500 Holter recorder and were instructed to indicate the
start and finish of each walk by pressing the event button.
Holter recordings and analysis. Three Holter leads, com-
parable to leads V5, V3 and aVF were used. The recordings
were initially analyzed in the Marquette Series 8000 Holter
Analysis System with use of the 5.8 software version for ST
segment analysis by an expert technician who was required to
confirm the start of the ST segment depression and to define
normal and abnormal beats (ventricular extrasystoles, su-
praventricular extrasystoles and noise). The analyzed digital
data were then transferred from the Marquette system to our
departmental computer data base. Each patient’s Holter data
were analyzed by using the data search functions of the
Microsoft Excel 4.0 electronic spreadsheet, so that maximal
and minimal values of ST depression for any given heart rate
could be assessed. The lead chosen for each patient was the
one that showed the most prominent ischemic change during
the first walk; this lead was then used for comparison of all
three walks.
For each walk, the following variables were recorded: heart
rate at 1-mm ST depression, maximal ST depression, maximal
heart rate, normalized ST depression (which is the maximal ST
depression at the same heart rate in each of the three walks)
and the duration of ischemia.
Data analysis. All data were entered onto a computerized
spreadsheet. The mean value and SD were calculated for all
variables for each of the walks. Ischemia duration was com-
pared by using a Friedman analysis of variance; all other data
for the three walks were compared by using both a two-tailed
paired Student t test and repeated measures analysis based on
a multivariate approach. The assumptions of normality under-
lying the analysis of repeated measures analysis of variance
were examined. Heart rate at 1-mm ST depression and maxi-
mal heart rate were approximately normal. Maximal ST de-
pression and normalized maximal ST depression were approx-
imately normal after a logarithmic transformation. No suitable
transformation was found for duration of ischemia, so a
nonparametric analysis of variance was used to compare the
three walks. A difference was considered significant at p ,
0.05. For the purposes of this study we defined significant
change in any variable of ischemia as a change of 10% between
the first walk and the two later walks, so as to establish which
patients showed improvement in ischemia and in which vari-
able.
Results
Twenty patients completed all three walks as specified; one
patient performed only two of the three walks. Mean maximal
ST depression decreased from 2.21 mm during the first walk to
1.61 mm in the second walk and to 1.43 mm in the third (p 5
0.001) (Table 1, Fig. 1). Normalized maximal ST depression
decreased from 1.95 mm in the first walk to 1.41 mm in the
second and 1.18 mm in the third (p 5 0.002). Ischemia
Abbreviations and Acronyms
AEM 5 ambulatory electrocardiographic monitoring
ECG 5 electrocardiographic
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duration decreased from 514 s in the first walk to 228 s in the
second and to 254 s in the third walk (p 5 0.012) (Fig. 2).
There was an insignificant trend to increase in heart rate at
1-mm ST depression between the three walks which was not
significant (p 5 0.058). There was no change in the maximal
heart rates achieved in the three walks. Figures 3 and 4 show
representative AEM strips of patients with evidence of re-
duced myocardial ischemia on successive walks.
A variable was regarded as being improved if the improve-
ment was $10% in the second and third walks as compared to the
first. Not all variables showed the same extent of change from the
baseline. Table 2 shows the number of patients who showed
improvement in each variable in the second and third walks. In 19
of the 21 patients, improvement in at least one variable was
observed. Maximal ST depression, normalized maximal ST de-
pression and ischemia duration showed improvement in 65% of
the patients during the second or third walk. Most patients (76%)
had improvement in two or more variables. The most sensitive
variables exhibiting improvement were normalized ST depression
(17 patients) and ischemia duration (15 patients). The most
prominent improvement was observed in ischemia duration,
which was reduced by 55%.
Discussion
Attenuation of myocardial ischemia was observed in this
study during repeated daily ischemic episodes in 19 of 21
patients with coronary artery disease. The most striking im-
provement was observed in ischemia duration, which was
reduced by 55% (from 513 s to 228 s) in the whole group. The
15 patients whose ischemia duration was reduced by .10%
had an even more striking reduction from 554 s to 122 s (78%
reduction). The maximal ST depression was reduced from
Figure 1. Reduction in maximal ST segment depression (STD) is seen
during the three walks. Data are presented as mean value 6 1 SD.
Figure 2. Marked attenuation in ischemia duration is seen during the
three walks. Data are presented as mean value 6 1 SD.
Table 1. Results of the Three Walks
HR at 1-mm STD
(beats/min)
Max HR
(beats/min)
Max STD
(mm)
Normalized
Max STD (mm)
Ischemia
Duration (s)
Walk 1
Mean 99.5 112.8 2.21 1.95 513.8
SD 13.2 13.7 1.10 1.16 343.9
Walk 2
Mean 101.3 112.4 1.61 1.41 228.5
SD 16.0 16.3 1.10 1.02 295.2
Walk 3
Mean 105.8 113.4 1.43 1.18 253.5
SD 16.4 17.3 1.01 0.97 328.6
Analysis of variance (p value) 0.058* 0.967* 0.001* 0.002* 0.012†
Paired Student t test (p value)
Walk 1 vs. walk 2 0.325 0.793 0.001 0.00024 0.003
Walk 1 vs. walk 3 0.017 0.974 0.0002 0.00001 0.003
*Repeated measures analysis. †Friedman analysis of variance. HR 5 heart rate; Max 5 maximal; STD 5 ST segment
depression.
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2.2 mm on the first walk to 1.6 mm and 1.4 mm, respectively,
on the second and third walks. Ischemic threshold (heart rate
at 1-mm ST depression) increased from 99 beats/min on the
first walk to 106 beats/min on the third walk. All of these
changes occurred despite identical maximal heart rate in all
three walks. It seems, therefore, that this attenuation of
ischemia is due not to a training effect that enabled the patients
to perform a higher level of exercise, but rather to local
myocardial protection.
Analysis of variance with repeated measures revealed sig-
nificant differences among the three walks in maximal ST
depression, normalized maximal ST segment depression and
ischemia duration. Further analysis with two-tailed paired
Student t test showed that the improvement in these variables
was evident in both the second and third walks relative to the
first. Although statistical significance was not reached for heart
rate at 1-mm ST segment depression by using repeated mea-
sures analysis (p 5 0.058), a Student t test did reveal a
significant difference in this variable between the first and the
third walk, with no such significance shown for the second
walk. In combination, these analyses suggest that examination
of three of the variables revealed a significant decrease in
ischemia in the second walk that persisted in the third walk.
Attenuation of the severity of ischemia was observed in
most patients in this study. In 16 (67%) of the 21 patients, the
improvement was observed in two or more variables; the most
significant of which was duration of ischemia (total ischemic
burden). The clinical significance of the development of myo-
cardial protection is not clear. Because it occurs frequently, it
probably provides protection when several ischemic episodes
occur in succession. Our findings provide for the first time
ECG documentation of a long-known entity: walk-through
angina or warm-up phenomenon. In fact, a much more com-
mon phenomenon is walk-through ischemia as only a small
number of patients manifest symptoms with all ischemic epi-
sodes. Without the use of AEM, we could not have docu-
mented this phenomenon. Few previous studies have looked at
the influence of one exercise test on another exercise test
performed shortly thereafter. In the studies of Jaffe and Quin
(16) and Okazaki et al. (39), the patients performed two
exercise tests. A reduction in ischemia in the second of the two
tests was found. These authors use the term warm-up to
describe this phenomenon. Okazaki et al. showed that the
decrease in ischemic changes during the second of the two
exercise tests was not accompanied by an increase in coronary
flow. In a recent study, we (40) observed improvement in
ischemic variables in three exercise tests performed at 30-min
intervals. In that study the patients also performed additional
tests on the 2 days before the study in order to exclude the
training effect.
The increase in ischemic threshold between the first and
third walks observed in our present study also suggests the
Figure 3. ST segment and heart rate (HR) histogram. During the
three walks, there was a similar increase in heart rate (bottom panel,
from 92 to 101 and 95 beats/min, respectively), but the degree of ST
segment depression in leads V5 and V3 was markedly attenuated.
Figure 4. Electrocardiographic tracing demonstrating three ischemic
episodes during the three walks in a 62-year old man. Despite a similar
heart rate (HR: 96 to 97 beats/min), the degree of ST segment
depression decreased (ST2) after the first walk.
Table 2. Number of Patients Showing Improvement for Each
Ischemic Variable
Variable Walk 2 Walk 3 Both
HR at 1-mm STD 2 5 2
Maximal STD 14 16 12
Normalized Max STD 15 17 14
Ischemia duration 15 14 12
Abbreviations as in Table 1.
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development of local metabolic protection, which was similarly
demonstrated during preconditioning in animal experiments.
However, we cannot rule out the possibility that collateral
vessels were recruited or even that local vascular adaptation
(41,42) played a role in this protection.
Recent studies (33,34) have suggested that preconditioning
provides substantial and prolonged protection in patients who
subsequently have a myocardial infarction. Patients who had
preceding angina had a smaller infarct size and a reduced
incidence of death, congestive heart failure and cardiogenic
shock. This protection was present in patients who had angina
during the 24 h and even 48 h preceding the infarct. Thus, the
precise conditions under which ischemic preconditioning de-
velops and the type and extent of protection it provides are far
from clear. In conclusion, this study demonstrated attenuation
of myocardial ischemia in patients with frequent and adjacent
ischemic episodes. This form of protection is probably the
clinical counterpart of myocardial preconditioning, which so
far has only been described during repeated coronary occlu-
sions.
The invaluable assistance of Noemie Bloch in AEM analysis is greatly appreci-
ated.
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